These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16545770)

  • 21. Amiodarone analog-dependent effects on CYP2C9-mediated metabolism and kinetic profiles.
    Kumar V; Locuson CW; Sham YY; Tracy TS
    Drug Metab Dispos; 2006 Oct; 34(10):1688-96. PubMed ID: 16815961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the bound substrate in nitric oxide synthase protonated or neutral and what is the active oxidant that performs substrate hydroxylation?
    de Visser SP; Tan LS
    J Am Chem Soc; 2008 Oct; 130(39):12961-74. PubMed ID: 18774806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P450 on drugs.
    Jabri E
    Nat Struct Biol; 2003 Aug; 10(8):587. PubMed ID: 12886290
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of comparative cytochrome P450 2B4 model by photoaffinity labeling.
    Hodek P; Sopko B; Antonovic L; Sulc M; Novák P; Strobel HW
    Gen Physiol Biophys; 2004 Dec; 23(4):467-88. PubMed ID: 15815081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the nitrosyl adduct of substrate-bound mouse cysteine dioxygenase by electron paramagnetic resonance: electronic structure of the active site and mechanistic implications.
    Pierce BS; Gardner JD; Bailey LJ; Brunold TC; Fox BG
    Biochemistry; 2007 Jul; 46(29):8569-78. PubMed ID: 17602574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping of cytochrome P450 2B4 substrate binding sites by photolabile probe 3-azidiamantane: identification of putative substrate access regions.
    Hodek P; Karabec M; Sulc M; Sopko B; Smrcek S; Martínek V; Hudecek J; Stiborová M
    Arch Biochem Biophys; 2007 Dec; 468(1):82-91. PubMed ID: 17961497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new class of CYP2C9 inhibitors: probing 2C9 specificity with high-affinity benzbromarone derivatives.
    Locuson CW; Wahlstrom JL; Rock DA; Rock DA; Jones JP
    Drug Metab Dispos; 2003 Jul; 31(7):967-71. PubMed ID: 12814975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role of the heme-7-propionate side chain in cytochrome P450cam as a gate for regulating the access of water molecules to the substrate-binding site.
    Hayashi T; Harada K; Sakurai K; Shimada H; Hirota S
    J Am Chem Soc; 2009 Feb; 131(4):1398-400. PubMed ID: 19133773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of CYP2C9 inhibition by flavones and flavonols.
    Si D; Wang Y; Zhou YH; Guo Y; Wang J; Zhou H; Li ZS; Fawcett JP
    Drug Metab Dispos; 2009 Mar; 37(3):629-34. PubMed ID: 19074529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The second step of the nitric oxide synthase reaction: evidence for ferric-peroxo as the active oxidant.
    Woodward JJ; Chang MM; Martin NI; Marletta MA
    J Am Chem Soc; 2009 Jan; 131(1):297-305. PubMed ID: 19128180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structures of two aromatic hydroxylases involved in the early tailoring steps of angucycline biosynthesis.
    Koskiniemi H; Metsä-Ketelä M; Dobritzsch D; Kallio P; Korhonen H; Mäntsälä P; Schneider G; Niemi J
    J Mol Biol; 2007 Sep; 372(3):633-48. PubMed ID: 17669423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel iron(III) porphyrazine complex. Complex speciation and reactions with NO and H2O2.
    Theodoridis A; Maigut J; Puchta R; Kudrik EV; van Eldik R
    Inorg Chem; 2008 Apr; 47(8):2994-3013. PubMed ID: 18351731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unique binding of a non-natural L,L,L-substrate by isopenicillin N synthase.
    Howard-Jones AR; Rutledge PJ; Clifton IJ; Adlington RM; Baldwin JE
    Biochem Biophys Res Commun; 2005 Oct; 336(2):702-8. PubMed ID: 16143309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What factors influence the ratio of C-H hydroxylation versus C=C epoxidation by a nonheme cytochrome P450 biomimetic?
    de Visser SP
    J Am Chem Soc; 2006 Dec; 128(49):15809-18. PubMed ID: 17147391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dioxygen activation at non-heme iron: insights from rapid kinetic studies.
    Korendovych IV; Kryatov SV; Rybak-Akimova EV
    Acc Chem Res; 2007 Jul; 40(7):510-21. PubMed ID: 17521158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two alternative substrate paths for compound I formation and reduction in catalase-peroxidase KatG from Burkholderia pseudomallei.
    Deemagarn T; Wiseman B; Carpena X; Ivancich A; Fita I; Loewen PC
    Proteins; 2007 Jan; 66(1):219-28. PubMed ID: 17063492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spin-spin coupling constants in homonuclear polynitrogen species.
    Bryce DL
    Phys Chem Chem Phys; 2006 Aug; 8(29):3379-82. PubMed ID: 16855714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrogen peroxide decomposition by a non-heme iron(III) catalase mimic: a DFT study.
    Sicking W; Korth HG; Jansen G; de Groot H; Sustmann R
    Chemistry; 2007; 13(15):4230-45. PubMed ID: 17323385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Hydroxylation Position Rather than Chirality Determines How Efavirenz Metabolites Activate Cytochrome P450 46A1 In Vitro.
    Mast N; Fotinich A; Pikuleva IA
    Drug Metab Dispos; 2022 Jul; 50(7):923-930. PubMed ID: 35489779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and Metabolism.
    Bostick CD; Hickey KM; Wollenberg LA; Flora DR; Tracy TS; Gannett PM
    Drug Metab Dispos; 2016 May; 44(5):741-9. PubMed ID: 26961240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.